Literature DB >> 10720582

Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction.

C Hengstenberg1, S R Holmer, B Mayer, H Löwel, S Engel, H W Hense, G A Riegger, H Schunkert.   

Abstract

Left ventricular remodeling after myocardial infarction involves activation of the renin-angiotensin-aldosterone system. Recently, the biallelic -344T/C polymorphism of the aldosterone synthase gene was associated with increased aldosterone levels, arterial hypertension, diastolic dysfunction, and left ventricular dilatation. We hypothesized that this polymorphism may also affect left ventricular geometry and function after myocardial infarction. By using a standardized questionnaire, as well as anthropometric and echocardiographic measurements, we thus studied 606 patients (533 men and 73 women) who had a myocardial infarction before the age of 60 years. The aldosterone synthase gene polymorphism was analyzed after polymerase chain reaction amplification and restriction enzyme digestion. The results demonstrated that there was no association of the aldosterone synthase gene polymorphism with echocardiographically determined left ventricular dimensions, wall thicknesses, or indexes of systolic or diastolic function. Furthermore, anthropometric data, including blood pressure levels, were balanced between the different genotypes. Finally, the allele frequency was similar for patients with myocardial infarction and a sample group from the normal population (n=1675). The data indicate that the allele status of the aldosterone synthase gene polymorphism is not useful for the identification of patients with myocardial infarction who have impaired left ventricular function or unfavorable remodeling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720582     DOI: 10.1161/01.hyp.35.3.704

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  Identification of chromosomal regions linked to premature myocardial infarction: a meta-analysis of whole-genome searches.

Authors:  Elias Zintzaras; Georgios Kitsios
Journal:  J Hum Genet       Date:  2006-09-22       Impact factor: 3.172

3.  Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trials.

Authors:  Arthur M Feldman; Lilin She; Dennis M McNamara; Douglas L Mann; Michael R Bristow; Alan S Maisel; Daniel R Wagner; Bert Andersson; Luigi Chiariello; Christopher S Hayward; Paul Hendry; John D Parker; Normand Racine; Craig H Selzman; Michele Senni; Janina Stepinska; Marian Zembala; Jean Rouleau; Eric J Velazquez; Kerry L Lee
Journal:  Cardiology       Date:  2015-01-13       Impact factor: 1.869

Review 4.  RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease.

Authors:  Jay Lakkis; Wei X Lu; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

5.  Relationship between CYP17A1 genetic polymorphism and coronary artery disease in a Chinese Han population.

Authors:  Chuan-Fang Dai; Xiang Xie; Yi-Ning Yang; Xiao-Mei Li; Ying-Ying Zheng; Zhen-Yan Fu; Fen Liu; Bang-Dang Chen; Min-Tao Gai; Yi-Tong Ma
Journal:  Lipids Health Dis       Date:  2015-03-07       Impact factor: 3.876

6.  The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China.

Authors:  Jin-Guo Zou; Yi-Tong Ma; Xiang Xie; Yi-Ning Yang; Shuo Pan; Dilare Adi; Fen Liu; Bang-Dang Chen
Journal:  Lipids Health Dis       Date:  2014-09-05       Impact factor: 3.876

7.  CYP11B2 T-344C gene polymorphism and atrial fibrillation: a meta-analysis of 2,758 subjects.

Authors:  Yan-yan Li; Chuan-wei Zhou; Jian Xu; Yun Qian; Bei Wang
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.